about
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agentsAntiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism.Immunohistochemical analysis of paraoxonases and chemokines in arteries of patients with peripheral artery disease.Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histologyMitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.Paraoxonases and chemokine (C-C motif) ligand-2 in noncommunicable diseases.Autophagy is an inflammation-related defensive mechanism against disease.Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study.Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Ubiquitous transgenic overexpression of C-C chemokine ligand 2: a model to assess the combined effect of high energy intake and continuous low-grade inflammation.Higher levels of IL-6, CD4 turnover and Treg frequency are already present before cART in HIV-infected subjects with later low CD4 recovery.HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.The acute impact of polyphenols from Hibiscus sabdariffa in metabolic homeostasis: an approach combining metabolomics and gene-expression analyses.PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study.The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patientsPlant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.Metformin: a cheap and well-tolerated drug that provides benefits for viral infections.Exploring PPAR modulation in experimental mice.Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of ART in HIV-infected patients.Altered expression of miR-181a-5p and miR-23a-3p is associated with obesity and TNFα-induced insulin resistance.Proteomic Profile Associated with Loss of Spontaneous HIV-1 Elite ControlMapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver diseaseUnderstanding the role of circulating chemokine (C-C motif) ligand 2 in patients with chronic ischemia threatening the lower extremitiesSerum fatty acid synthase concentration is increased in patients with hepatitis viral infection and may assist in the prediction of liver steatosisHibiscus sabdariffaextract lowers blood pressure and improves endothelial functionCirculating metabolomic profile can predict dyslipidemia in HIV patients undergoing antiretroviral therapy
P50
Q28395443-97D9E829-F4B0-40CA-9C0B-593482E7F65DQ34027872-7AF4F520-0224-4936-AE6C-93E91F02ABEEQ35723746-FBCB9A75-B87E-452A-9683-A92CAB0A95F6Q35783949-E52A6B28-9D1F-4770-A20F-63215C11A446Q38093566-2ECBACD5-BCDB-4A0E-AD52-B1D52F4C1F14Q38208334-72C71279-B113-45B9-8E73-8388C20E0EACQ38231260-33FC984A-C39B-41E4-8C46-8B70ED05487AQ38309329-82F62113-4490-4747-9B95-EF8BBF6A8E78Q38834406-732BE52E-624A-4F77-B5A8-EE2FCA1ED80EQ39247899-3E19AD31-1C69-4DB6-849B-5463929CA5B7Q39266499-CEFF9248-411E-4BB9-BBD2-E00D0B0D7FA5Q40278234-4225C48F-501A-42C6-A064-27C0EFF3E9E0Q40406168-385F046E-1DED-4F41-8A3C-5651434FD85FQ40668617-A5811764-D2EF-4B2B-9008-125C3DC297E8Q40793611-2EA62321-75BF-4555-9265-6C56BBDBC6ADQ41024442-1DEC913B-29A3-45F4-92E9-7BB526F2757AQ42175449-68C99869-F7DA-4ECE-86E6-039E7F075D1AQ42644215-7EEFF4D7-9756-4F3B-8554-480B40E91BFCQ45961719-52560E2B-79B6-41EC-BA69-D2E8BB6CF5D4Q46646535-EF6BC5A2-C199-418D-9DF4-9CCA7AAB1743Q47174478-59BA6541-48AF-4F78-839B-A0833818EDFAQ47216380-D6247803-CA1B-455A-9A06-55CC2F2BDC03Q50148743-6AE8CEEE-1B81-4266-9D91-C7B9A318658EQ57471553-B4D5A28A-06A6-46E9-803B-6D0ADE2BA5D9Q57559177-41DB6D3E-E098-4D6C-AE43-BBF11DF8B0CCQ59450035-BA207186-3284-4107-8D66-C178BEA3563FQ59450122-2B20D6D9-A70C-4F55-8747-11DCC7355A67Q60634086-070E829F-05F4-43B9-9386-48129AF515E0Q88423414-2B5FB487-4D52-4E10-867E-852697C44F5A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Esther Rodríguez-Gallego
@ast
Esther Rodríguez-Gallego
@en
Esther Rodríguez-Gallego
@es
Esther Rodríguez-Gallego
@nl
Esther Rodríguez-Gallego
@sl
type
label
Esther Rodríguez-Gallego
@ast
Esther Rodríguez-Gallego
@en
Esther Rodríguez-Gallego
@es
Esther Rodríguez-Gallego
@nl
Esther Rodríguez-Gallego
@sl
prefLabel
Esther Rodríguez-Gallego
@ast
Esther Rodríguez-Gallego
@en
Esther Rodríguez-Gallego
@es
Esther Rodríguez-Gallego
@nl
Esther Rodríguez-Gallego
@sl
P108
P1053
B-6581-2016
P106
P1153
52564288900
P21
P31
P3829
P496
0000-0002-6363-2510